This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ueki, K.
Right arrow Articles by Kahn, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ueki, K.
Right arrow Articles by Kahn, C. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2004, p. 5434-5446, Vol. 24, No. 12
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.12.5434-5446.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms

Kohjiro Ueki,{dagger} Tatsuya Kondo, and C. Ronald Kahn*

Research Division, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts

Received 2 October 2003/ Returned for modification 3 November 2003/ Accepted 20 March 2004

Insulin resistance is a pathophysiological component of type 2 diabetes and obesity and also occurs in states of stress, infection, and inflammation associated with an upregulation of cytokines. Here we show that in both obesity and lipopolysaccharide (LPS)-induced endotoxemia there is an increase in suppressor of cytokine signaling (SOCS) proteins, SOCS-1 and SOCS-3, in liver, muscle, and, to a lesser extent, fat. In concordance with these increases by LPS, tyrosine phosphorylation of the insulin receptor (IR) is partially impaired and phosphorylation of the insulin receptor substrate (IRS) proteins is almost completely suppressed. Direct overexpression of SOCS-3 in liver by adenoviral-mediated gene transfer markedly decreases tyrosine phosphorylation of both IRS-1 and IRS-2, while SOCS-1 overexpression preferentially inhibits IRS-2 phosphorylation. Neither affects IR phosphorylation, although both SOCS-1 and SOCS-3 bind to the insulin receptor in vivo in an insulin-dependent fashion. Experiments with cultured cells expressing mutant insulin receptors reveal that SOCS-3 binds to Tyr960 of IR, a key residue for the recognition of IRS-1 and IRS-2, whereas SOCS-1 binds to the domain in the catalytic loop essential for IRS-2 recognition in vitro. Moreover, overexpression of either SOCS-1 or SOCS-3 attenuates insulin-induced glycogen synthesis in L6 myotubes and activation of glucose uptake in 3T3L1 adipocytes. By contrast, a reduction of SOCS-1 or SOCS-3 by antisense treatment partially restores tumor necrosis factor alpha-induced downregulation of tyrosine phosphorylation of IRS proteins in 3T3L1 adipocytes. These data indicate that SOCS-1 and SOCS-3 act as negative regulators in insulin signaling and serve as one of the missing links between insulin resistance and cytokine signaling.

* Corresponding author. Mailing address: Joslin Diabetes Center, One Joslin Place, Boston, MA 02215. Phone: (617) 732-2635. Fax: (617) 732-2593. E-mail: c.ronald.kahn{at}joslin.harvard.edu.

{dagger} Present address: Department of Metabolic Diseases, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.

Molecular and Cellular Biology, June 2004, p. 5434-5446, Vol. 24, No. 12
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.12.5434-5446.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jorgensen, S. B., Honeyman, J., Oakhill, J. S., Fazakerley, D., Stockli, J., Kemp, B. E., Steinberg, G. R. (2009). Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 297: E57-E66 [Abstract] [Full Text]  
  • Yaspelkis, B. B. III, Kvasha, I. A., Figueroa, T. Y. (2009). High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKK{alpha}/{beta} phosphorylation and decreases PI-3 kinase activity in muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R1709-R1715 [Abstract] [Full Text]  
  • Gupta, A., Srinivasan, M., Thamadilok, S., Patel, M. S (2009). Hypothalamic alterations in fetuses of high fat diet-fed obese female rats. J Endocrinol 200: 293-300 [Abstract] [Full Text]  
  • Stefan, N., Kantartzis, K., Haring, H.-U. (2008). Causes and Metabolic Consequences of Fatty Liver. Endocr. Rev. 29: 939-960 [Abstract] [Full Text]  
  • Nieto-Vazquez, I., Fernandez-Veledo, S., de Alvaro, C., Lorenzo, M. (2008). Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle. Diabetes 57: 3211-3221 [Abstract] [Full Text]  
  • Shah, A., Mehta, N., Reilly, M. P. (2008). Adipose Inflammation, Insulin Resistance, and Cardiovascular Disease. JPEN J Parenter Enteral Nutr 32: 638-644 [Abstract] [Full Text]  
  • Zhang, R., Dhillon, H., Yin, H., Yoshimura, A., Lowell, B. B., Maratos-Flier, E., Flier, J. S. (2008). Selective Inactivation of Socs3 in SF1 Neurons Improves Glucose Homeostasis without Affecting Body Weight. Endocrinology 149: 5654-5661 [Abstract] [Full Text]  
  • Pedersen, B. K., Febbraio, M. A. (2008). Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6. Physiol. Rev. 88: 1379-1406 [Abstract] [Full Text]  
  • Holmes, A. G, Mesa, J. L, Neill, B. A, Chung, J., Carey, A. L, Steinberg, G. R, Kemp, B. E, Southgate, R. J, Lancaster, G. I, Bruce, C. R, Watt, M. J, Febbraio, M. A (2008). Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPAR{alpha} and UCP2 expression in rats. J Endocrinol 198: 367-374 [Abstract] [Full Text]  
  • Huang, X., Moore, D. J., Ketchum, R. J., Nunemaker, C. S., Kovatchev, B., McCall, A. L., Brayman, K. L. (2008). Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation. Endocr. Rev. 29: 603-630 [Abstract] [Full Text]  
  • Hadsell, D. L, Parlow, A. F, Torres, D., George, J., Olea, W. (2008). Enhancement of maternal lactation performance during prolonged lactation in the mouse by mouse GH and long-R3-IGF-I is linked to changes in mammary signaling and gene expression. J Endocrinol 198: 61-70 [Abstract] [Full Text]  
  • Urayama, A., Banks, W. A. (2008). Starvation and Triglycerides Reverse the Obesity-Induced Impairment of Insulin Transport at the Blood-Brain Barrier. Endocrinology 149: 3592-3597 [Abstract] [Full Text]  
  • Liu, X., Mameza, M. G., Lee, Y. S., Eseonu, C. I., Yu, C.-R., Kang Derwent, J. J., Egwuagu, C. E. (2008). Suppressors of Cytokine-Signaling Proteins Induce Insulin Resistance in the Retina and Promote Survival of Retinal Cells. Diabetes 57: 1651-1658 [Abstract] [Full Text]  
  • Carper, M. J., Cade, W. T., Cam, M., Zhang, S., Shalev, A., Yarasheski, K. E., Ramanadham, S. (2008). HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 294: E558-E567 [Abstract] [Full Text]  
  • Riehle, K. J., Campbell, J. S., McMahan, R. S., Johnson, M. M., Beyer, R. P., Bammler, T. K., Fausto, N. (2008). Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. JEM 205: 91-103 [Abstract] [Full Text]  
  • Oben, J. A, Paulon, E. (2007). Fatty liver in chronic hepatitis C infection: unravelling the mechanisms. Gut 56: 1186-1188 [Full Text]  
  • Li, L., Naples, M., Song, H., Yuan, R., Ye, F., Shafi, S., Adeli, K., Ng, D. S. (2007). LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling. Am. J. Physiol. Endocrinol. Metab. 293: E587-E594 [Abstract] [Full Text]  
  • Qatanani, M., Lazar, M. A. (2007). Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21: 1443-1455 [Abstract] [Full Text]  
  • Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., Schwartz, M. W. (2007). Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity. Circ. Res. 100: 1589-1596 [Abstract] [Full Text]  
  • Ishizuka, K., Usui, I., Kanatani, Y., Bukhari, A., He, J., Fujisaka, S., Yamazaki, Y., Suzuki, H., Hiratani, K., Ishiki, M., Iwata, M., Urakaze, M., Haruta, T., Kobayashi, M. (2007). Chronic Tumor Necrosis Factor-{alpha} Treatment Causes Insulin Resistance via Insulin Receptor Substrate-1 Serine Phosphorylation and Suppressor of Cytokine Signaling-3 Induction in 3T3-L1 Adipocytes. Endocrinology 148: 2994-3003 [Abstract] [Full Text]  
  • O'Connor, J. C., Sherry, C. L., Guest, C. B., Freund, G. G. (2007). Type 2 Diabetes Impairs Insulin Receptor Substrate-2-Mediated Phosphatidylinositol 3-Kinase Activity in Primary Macrophages to Induce a State of Cytokine Resistance to IL-4 in Association with Overexpression of Suppressor of Cytokine Signaling-3. J. Immunol. 178: 6886-6893 [Abstract] [Full Text]  
  • Ekstrom, K., Salemyr, J., Zachrisson, I., Carlsson-Skwirut, C., Ortqvist, E., Bang, P. (2007). Normalization of the IGF-IGFBP Axis by Sustained Nightly Insulinization in Type 1 Diabetes. Diabetes Care 30: 1357-1363 [Abstract] [Full Text]  
  • Endo, M., Masaki, T., Seike, M., Yoshimatsu, H. (2007). TNF-{alpha} Induces Hepatic Steatosis in Mice by Enhancing Gene Expression of Sterol Regulatory Element Binding Protein-1c (SREBP-1c). Exp. Biol. Med. 232: 614-621 [Abstract] [Full Text]  
  • Savage, D. B., Petersen, K. F., Shulman, G. I. (2007). Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance. Physiol. Rev. 87: 507-520 [Abstract] [Full Text]  
  • Brand, S., Dambacher, J., Beigel, F., Zitzmann, K., Heeg, M. H. J., Weiss, T. S., Prufer, T., Olszak, T., Steib, C. J., Storr, M., Goke, B., Diepolder, H., Bilzer, M., Thasler, W. E., Auernhammer, C. J. (2007). IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1019-G1028 [Abstract] [Full Text]  
  • Andersson, C. X., Sopasakis, V. R., Wallerstedt, E., Smith, U. (2007). Insulin Antagonizes Interleukin-6 Signaling and Is Anti-inflammatory in 3T3-L1 Adipocytes. J. Biol. Chem. 282: 9430-9435 [Abstract] [Full Text]  
  • Kanatani, Y., Usui, I., Ishizuka, K., Bukhari, A., Fujisaka, S., Urakaze, M., Haruta, T., Kishimoto, T., Naka, T., Kobayashi, M. (2007). Effects of Pioglitazone on Suppressor of Cytokine Signaling 3 Expression: Potential Mechanisms for Its Effects on Insulin Sensitivity and Adiponectin Expression. Diabetes 56: 795-803 [Abstract] [Full Text]  
  • Mooney, R. A. (2007). COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS. J. Appl. Physiol. 102: 816-818 [Full Text]  
  • Pedersen, B. K., Febbraio, M. A., Mooney, R. A. (2007). Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J. Appl. Physiol. 102: 814-816 [Full Text]  
  • Torisu, T., Sato, N., Yoshiga, D., Kobayashi, T., Yoshioka, T., Mori, H., Iida, M., Yoshimura, A. (2007). The dual function of hepatic SOCS3 in insulin resistance in vivo.. GENES CELLS 12: 143-154 [Abstract] [Full Text]  
  • Xu, A. W., Ste-Marie, L., Kaelin, C. B., Barsh, G. S. (2007). Inactivation of Signal Transducer and Activator of Transcription 3 in Proopiomelanocortin (Pomc) Neurons Causes Decreased Pomc Expression, Mild Obesity, and Defects in Compensatory Refeeding. Endocrinology 148: 72-80 [Abstract] [Full Text]  
  • Jager, J., Gremeaux, T., Cormont, M., Le Marchand-Brustel, Y., Tanti, J.-F. (2007). Interleukin-1{beta}-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression. Endocrinology 148: 241-251 [Abstract] [Full Text]  
  • Lumeng, C. N., Deyoung, S. M., Saltiel, A. R. (2007). Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292: E166-E174 [Abstract] [Full Text]  
  • Ropelle, E. R., Pauli, J. R., Prada, P. O., de Souza, C. T., Picardi, P. K., Faria, M. C., Cintra, D. E., Fernandes, M. F. d. A., Flores, M. B., Velloso, L. A., Saad, M. J. A., Carvalheira, J. B. C. (2006). Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation. J. Physiol. 577: 997-1007 [Abstract] [Full Text]  
  • Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., Kemp, B. E., Pedersen, B. K., Febbraio, M. A. (2006). Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein Kinase.. Diabetes 55: 2688-2697 [Abstract] [Full Text]  
  • Miao, T., Wu, D., Zhang, Y., Bo, X., Subang, M. C., Wang, P., Richardson, P. M. (2006). Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons.. J. Neurosci. 26: 9512-9519 [Abstract] [Full Text]  
  • Changolkar, L. N., Pehrson, J. R. (2006). macroH2A1 Histone Variants Are Depleted on Active Genes but Concentrated on the Inactive X Chromosome. Mol. Cell. Biol. 26: 4410-4420 [Abstract] [Full Text]  
  • Spangenburg, E. E., Brown, D. A., Johnson, M. S., Moore, R. L. (2006). Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J. Physiol. 572: 839-848 [Abstract] [Full Text]  
  • Haddad, F., Adams, G. R. (2006). Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J. Appl. Physiol. 100: 1188-1203 [Abstract] [Full Text]  
  • Walsh, M J, Jonsson, J R, Richardson, M M, Lipka, G M, Purdie, D M, Clouston, A D, Powell, E E (2006). Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut 55: 529-535 [Abstract] [Full Text]  
  • He, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., Kobayashi, M. (2006). Interleukin-1{alpha} Inhibits Insulin Signaling with Phosphorylating Insulin Receptor Substrate-1 on Serine Residues in 3T3-L1 Adipocytes. Mol. Endocrinol. 20: 114-124 [Abstract] [Full Text]  
  • Laubner, K., Kieffer, T. J., Lam, N. T., Niu, X., Jakob, F., Seufert, J. (2005). Inhibition of Preproinsulin Gene Expression by Leptin Induction of Suppressor of Cytokine Signaling 3 in Pancreatic {beta}-Cells. Diabetes 54: 3410-3417 [Abstract] [Full Text]  
  • Kim, B., van Golen, C. M., Feldman, E. L. (2005). Insulin-Like Growth Factor I Induces Preferential Degradation of Insulin Receptor Substrate-2 through the Phosphatidylinositol 3-Kinase Pathway in Human Neuroblastoma Cells. Endocrinology 146: 5350-5357 [Abstract] [Full Text]  
  • Nguyen, M. T. A., Satoh, H., Favelyukis, S., Babendure, J. L., Imamura, T., Sbodio, J. I., Zalevsky, J., Dahiyat, B. I., Chi, N.-W., Olefsky, J. M. (2005). JNK and Tumor Necrosis Factor-{alpha} Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes. J. Biol. Chem. 280: 35361-35371 [Abstract] [Full Text]  
  • Lindberg, K, Ronn, S G, Tornehave, D, Richter, H, Hansen, J A, Romer, J, Jackerott, M, Billestrup, N (2005). Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3. J Mol Endocrinol 35: 231-243 [Abstract] [Full Text]  
  • Bruunsgaard, H. (2005). Physical activity and modulation of systemic low-level inflammation. J. Leukoc. Biol. 78: 819-835 [Abstract] [Full Text]  
  • Jamieson, E., Chong, M. M. W., Steinberg, G. R., Jovanovska, V., Fam, B. C., Bullen, D. V. R., Chen, Y., Kemp, B. E., Proietto, J., Kay, T. W. H., Andrikopoulos, S. (2005). Socs1 Deficiency Enhances Hepatic Insulin Signaling. J. Biol. Chem. 280: 31516-31521 [Abstract] [Full Text]  
  • Klover, P. J., Clementi, A. H., Mooney, R. A. (2005). Interleukin-6 Depletion Selectively Improves Hepatic Insulin Action in Obesity. Endocrinology 146: 3417-3427 [Abstract] [Full Text]  
  • Zekry, A, McHutchison, J G, Diehl, A M (2005). Insulin resistance and steatosis in hepatitis C virus infection. Gut 54: 903-906 [Full Text]  
  • Williamson, D. L., Kimball, S. R., Jefferson, L. S. (2005). Acute treatment with TNF-{alpha} attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism. Am. J. Physiol. Endocrinol. Metab. 289: E95-E104 [Abstract] [Full Text]  
  • Porte, D. Jr., Baskin, D. G., Schwartz, M. W. (2005). Insulin Signaling in the Central Nervous System: A Critical Role in Metabolic Homeostasis and Disease From C. elegans to Humans. Diabetes 54: 1264-1276 [Abstract] [Full Text]  
  • Savage, D. B., Petersen, K. F., Shulman, G. I. (2005). Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation. Hypertension 45: 828-833 [Abstract] [Full Text]  
  • Spangenburg, E. E. (2005). SOCS-3 Induces Myoblast Differentiation. J. Biol. Chem. 280: 10749-10758 [Abstract] [Full Text]  
  • Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., Lazar, M. A. (2005). Activation of SOCS-3 by Resistin. Mol. Cell. Biol. 25: 1569-1575 [Abstract] [Full Text]  
  • Schwartz, M. W., Porte, D. Jr. (2005). Diabetes, Obesity, and the Brain. Science 307: 375-379 [Abstract] [Full Text]  
  • Rhodes, C. J. (2005). Type 2 Diabetes-a Matter of {beta}-Cell Life and Death?. Science 307: 380-384 [Abstract] [Full Text]  
  • Schwartz, M. W., Niswender, K. D. (2004). Adiposity Signaling and Biological Defense Against Weight Gain: Absence of Protection or Central Hormone Resistance?. J. Clin. Endocrinol. Metab. 89: 5889-5897 [Abstract] [Full Text]  
  • Metzger, S., Nusair, S., Planer, D., Barash, V., Pappo, O., Shilyansky, J., Chajek-Shaul, T. (2004). Inhibition of Hepatic Gluconeogenesis and Enhanced Glucose Uptake Contribute to the Development of Hypoglycemia in Mice Bearing Interleukin-1{beta}- Secreting Tumor. Endocrinology 145: 5150-5156 [Abstract] [Full Text]  
  • Ueki, K., Kondo, T., Tseng, Y.-H., Kahn, C. R. (2004). Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. USA 101: 10422-10427 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»